WallStreetZenWallStreetZen

NASDAQ: OMGA
Omega Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for OMGA

Based on 4 analysts offering 12 month price targets for Omega Therapeutics Inc.
Min Forecast
$7.00+243.14%
Avg Forecast
$10.00+390.2%
Max Forecast
$12.00+488.24%

Should I buy or sell OMGA stock?

Based on 4 analysts offering ratings for Omega Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OMGA stock forecasts and price targets.

OMGA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-18
lockedlocked$00.00+00.00%2024-05-13
lockedlocked$00.00+00.00%2024-05-07
lockedlocked$00.00+00.00%2024-04-03

1 of 1

Forecast return on equity

Is OMGA forecast to generate an efficient return?
Company
-134.04%
Industry
73.55%
Market
80.58%
OMGA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OMGA forecast to generate an efficient return on assets?
Company
-30.18%
Industry
31.45%
OMGA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OMGA earnings per share forecast

What is OMGA's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$1.31
Avg 2 year Forecast
-$1.19
Avg 3 year Forecast
-$1.25

OMGA revenue forecast

What is OMGA's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$6.0M+22.03%
Avg 2 year Forecast
$3.9M-20.69%
Avg 3 year Forecast
$26.8M+442.07%
OMGA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OMGA revenue growth forecast

How is OMGA forecast to perform vs Biotechnology companies and vs the US market?
Company
46.96%
Industry
37.21%
Market
10.62%
OMGA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OMGA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OMGA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OMGA$2.04$10.00+390.20%Strong Buy
CRDF$2.51$10.50+318.33%Strong Buy
RGLS$1.71$11.00+543.27%Buy
ARMP$3.15$7.00+122.22%Buy
KPTI$0.94$7.00+641.53%Buy

Omega Therapeutics Stock Forecast FAQ

Is Omega Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OMGA) stock is to Strong Buy OMGA stock.

Out of 4 analysts, 2 (50%) are recommending OMGA as a Strong Buy, 2 (50%) are recommending OMGA as a Buy, 0 (0%) are recommending OMGA as a Hold, 0 (0%) are recommending OMGA as a Sell, and 0 (0%) are recommending OMGA as a Strong Sell.

If you're new to stock investing, here's how to buy Omega Therapeutics stock.

What is OMGA's earnings growth forecast for 2024-2026?

(NASDAQ: OMGA) Omega Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.03%.

Omega Therapeutics's earnings in 2024 is -$92,278,000.On average, 6 Wall Street analysts forecast OMGA's earnings for 2024 to be -$72,253,030, with the lowest OMGA earnings forecast at -$83,284,027, and the highest OMGA earnings forecast at -$62,876,683. On average, 6 Wall Street analysts forecast OMGA's earnings for 2025 to be -$65,358,657, with the lowest OMGA earnings forecast at -$98,727,423, and the highest OMGA earnings forecast at -$45,778,638.

In 2026, OMGA is forecast to generate -$68,667,956 in earnings, with the lowest earnings forecast at -$93,211,925 and the highest earnings forecast at -$44,123,988.

What is OMGA's revenue growth forecast for 2024-2026?

(NASDAQ: OMGA) Omega Therapeutics's forecast annual revenue growth rate of 46.96% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.21%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.62%.

Omega Therapeutics's revenue in 2024 is $4,939,000.On average, 4 Wall Street analysts forecast OMGA's revenue for 2024 to be $332,419,095, with the lowest OMGA revenue forecast at $212,898,242, and the highest OMGA revenue forecast at $526,178,557. On average, 4 Wall Street analysts forecast OMGA's revenue for 2025 to be $216,042,076, with the lowest OMGA revenue forecast at $82,732,478, and the highest OMGA revenue forecast at $373,399,248.

In 2026, OMGA is forecast to generate $1,476,664,413 in revenue, with the lowest revenue forecast at $1,476,664,413 and the highest revenue forecast at $1,476,664,413.

What is OMGA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OMGA) forecast ROA is -30.18%, which is lower than the forecast US Biotechnology industry average of 31.45%.

What is OMGA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OMGA price target, the average OMGA price target is $10.00, with the highest OMGA stock price forecast at $12.00 and the lowest OMGA stock price forecast at $7.00.

On average, Wall Street analysts predict that Omega Therapeutics's share price could reach $10.00 by Jun 18, 2025. The average Omega Therapeutics stock price prediction forecasts a potential upside of 390.2% from the current OMGA share price of $2.04.

What is OMGA's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: OMGA) Omega Therapeutics's current Earnings Per Share (EPS) is -$1.66. On average, analysts forecast that OMGA's EPS will be -$1.31 for 2024, with the lowest EPS forecast at -$1.51, and the highest EPS forecast at -$1.14. On average, analysts forecast that OMGA's EPS will be -$1.19 for 2025, with the lowest EPS forecast at -$1.79, and the highest EPS forecast at -$0.83. In 2026, OMGA's EPS is forecast to hit -$1.25 (min: -$1.69, max: -$0.80).

What is OMGA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OMGA) forecast ROE is -134.04%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.